Danone Asia Pacific Holdings Pte. Ltd. engages in dairy products production. The firm offers liquid milk, ice cream, milk formula and other products. The company is headquartered in Singapore.

SyntheX created a novel cell-based, synthetic biology-driven drug selection platform, that allows for the efficient synthesis and identification of peptides and macrocycles that selectively disrupt intracellular protein-protein interactions of interest. Although the platform has broad application, the initial focus is on oncology. Targets are selected based on the concepts of synthetic lethality and oncogene addiction, with the first program focused on DNA damage repair and working through a novel cell death mechanism that was uncovered.

Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Wuhu Fumin Bio-Pharmaceutical Co., Ltd., established on 2013-07-15, Business scope includes biomedicine,Chemical raw materials and products(In addition to dangerous goods)research and development(In addition to production);Production of Glycerophosphatidylcholine(Except for pre-licensing);calcium phosphate,Potassium Chloride Sales(The above scope except hazardous chemicals);API R&D(In addition to production)and related technical advice,technology transfer,Technical Services;Self-operated and agent import and export of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of),Phosphatidylserine Production,Sales(Except for pre-licensing).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Bristol Laboratories Ltd., a subsidiary of B. R. & L. Investments Ltd., is a British company located in Berkhamstead that develops, manufactures and markets generic medicines. It was founded in 1997.\nThe company says this about itself: Established in 1997, Bristol Laboratories is a fast growing British pharmaceutical company engaged in the development, manufacture, marketing and distribution of generic medicines in the UK and Europe. We work towards offering a wide range of high-quality medicines to the healthcare sector in the UK, that optimises cost efficiencies whilst ensuring reliable supply.Our strong and extensive customer base, developed through consistency of quality in products and services, has ensured sustained growth that continues to drive our ambitions to become a significant global supplier.

The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan, by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, which were specifically designed to be easily digested. These could be "reduced to a powder under the thumb", a strong marketing argument at the time.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Juno Online Services is an internet service provider. The company provides internet-related services in North America. Juno Online Services offers services including free basic internet access solutions, billable premium dial-up services, and high-speed broadband access solutions. It operates as a subsidiary of United Online. Founded in 1996 by Charles Ardai, Juno Online Services is based in Woodland Hills, California.

Societ�� Prodotti Antibiotici SpA is a pharmaceutical firm. The company was founded in 1947 and is headquartered in Milan, Italy.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Xuzhou Shunping Biotechnology Co., Ltd., established on 2016-04-28, Business scope includes biotechnology research and development,technical consulting,technology transfer,Technical Services,Chemical raw materials and products(except dangerous goods),laboratory instrument,Equipment,electronic product(except medical devices),Instrument sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of ABD 2010 Ltd., Original Image Ltd. is an of New Zealand company. The firm operates as web development company.

Anhui Oz Information Technology Co., Ltd. was established on April 18, 2016. Its business scope includes computer information technology development, simulation technology research and development, game equipment, computer software and hardware development and sales, and computer system integration. (Projects subject to approval according to law can only carry out business activities after approval by relevant departments)***

Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing clinically effective anti-infective treatments against serious and often life-threatening infections. With over 100 years of pharmaceutical industry expertise, we are a leading developer, manufacturer and trusted supplier of fermented and semi-synthetic Active Pharmaceutical Ingredients (APIs) and finished dosage forms (FDF), and the world-leading supplier of Vancomycin and Colistimethate Sodium (CMS). Our range of anti-infective treatments combat, most types of bacterial and antibiotic-resistant infections and certain fungal diseases. We have growing sales in more than 70 countries to over 700 customers and are continually developing and expanding our product range to meet new treatment needs and to better service our customers’ requirements. This includes developing new dosage forms using Xellia’s APIs, and if required APIs sourced from our network of suppliers. To complement our dry powder fill and freeze-dried vials for injectable delivery we are also developing innovative proprietary delivery systems and formulations for topical, inhaled or injectable administration either in house or through partnerships. We also offer contract manufacturing services and custom synthesis for clinical trial material supply. Xellia is a private company, with more than 850 employees and four state-of-the-art manufacturing facilities in Norway, Denmark, Hungary and China. We operate according to current Good Manufacturing Practice (cGMP) and our facilities have received regulatory approval from all relevant authorities, including the US Food and Drug Administration (FDA). Our operational headquarters are in Copenhagen, Denmark.